Transcription of Guideline on Process Validation - European Medicines Agency
{{id}} {{{paragraph}}}
Example: barber
Guideline on Process Validation - European Medicines Agency
7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8416 E-mail Website An Agency of the European Union European Medicines Agency , 2012. Reproduction is authorised provided the source is acknowledged. 1 2 3 4 5 6 29 March 2012 EMA/CHMP/CVMP/QWP/70278/2012-Rev1 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on Process Validation Draft Draft Agreed by CHMP / CVMP Quality Working Party 2 February 2012 Adoption by CVMP for release for consultation 8 March 2012 Adoption by CHMP for release for consultation 15 March 2012 End of consultation (deadline for comments)
validation and continuous process verification may be employed. The in-line, on-line or at-line monitoring that is often utilised for continuous process verification (discussed in section 5.2) provides ... tests to be performed and acceptance criteria, a description of the additional controls in place and the :
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: